Eisai Research Institute Implements ACD/Labs’ Processors throughout Discovery Research Facility
Advanced Chemistry Development, Inc., (ACD/Labs) today announced that Eisai Research Institute (ERI) has chosen ACD/Labs’ software to perform advanced spectral and chromatographic processing on their complex synthetic and organic chemical compounds.
ACD/1D NMR Processor, ACD/MS Processor, and ACD/ChromProcessor modules will be deployed onto desktops throughout the ERI facilities in Andover and Wilmington, Massachusetts, enabling scientists to process a wide range of instrument data file types using one common interface, and simultaneously granting access to universal chemical drawing and reporting capabilities.
Scientists at ERI will access ACD/Labs Processors through Synthematix’s ARTHUR™ Suite reaction planning software. Through an ongoing partnership between ACD/Labs and Synthematix, ARTHUR users can gain access to selected market-leading ACD/Labs tools from directly within the ARTHUR interface. ERI recently licensed ARTHUR to facilitate improved data communication between their discovery and process research groups, and plan to integrate ACD/Labs Processors with ARTHUR so that scientists will be able to retrieve, view, and process analytical data via the same familiar interface.
“We found the ACD/Labs software to be a flexible and comprehensive toolset that allows us to integrate analytical data of various types into our electronic notebook and archive system”, states Ted Suh, Ph.D., Director of Lead Identification at Eisai Research Institute.
Kevin Turnbull, Regional Sales Manager for ACD/Labs, adds, “We are delighted that Eisai Research Institute has chosen ACD/Labs Software to standardize the handling of spectral and chromatographic data within its research environment. The compatibility of the ACD/Labs Software with Synthematix ARTHUR Suite adds even greater impact because analytical data will be accessible to the chemists at ERI in a highly logical workflow.”
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics™. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
About Eisai Research Institute
Eisai Research Institute in Andover, Mass., is devoted to discovery research on complex synthetic and organic chemical compounds. Among the compounds discovered there are a potential treatment for sepsis and an anti-tumor agent, both currently in clinical trials. Eisai Research Institute also conducts process research and bulk production of pharmaceuticals for use in clinical trials. Process scientists determine the feasibility of pharmaceutical products for commercial production and prepare drug substances for formulation. Information about Eisai Research Institute and Eisai Inc. can be found at www.eisai.com .
About Synthematix
Synthematix, Inc., based in Research Triangle Park, NC, provides software for creating Comprehensive Chemistry Workflow Environments for synthetic chemists. Synthematix’s products consist of the Arthur™ Suite of software and informatics products as well as the Synthematix SubstructureSearch™ technology. These products allow chemists to build, access and mine chemical databases with unprecedented power and flexibility. ARTHUR™ users include ActivBiotics, Eisai Research Institute, Incyte Corporation, Inspire Pharmaceuticals, Plexxikon Corporation, Sigma Aldrich and other leading chemistry organizations. These tools and databases increase the effectiveness and efficiency of research chemists while permitting enhanced access to a company’s chemical R&D assets. Please visit www.synthematix.com for more information.
